Protein profile in breast cancer patients undergoing doxorubicin treatment : an iTRAQ-coupled LC-MS/MS approach
Chemotherapy is a common treatment for breast cancer and Doxorubicin is a common chemotherapeutic drug used for this purpose. However drug resistance is a great limitation to the effectiveness of chemotherapy treatment. It has been discovered that patients with single nucleotide polymorphism (SNP) i...
Saved in:
Main Author: | Cheah, Chee Liang. |
---|---|
Other Authors: | Chen Wei Ning, William |
Format: | Final Year Project |
Language: | English |
Published: |
2009
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/16544 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Identification of biomarker in patients on high dose warfarin : an iTRAQ-coupled LC-MS/MS approach
by: Lee, Joanne Hui Yi.
Published: (2009) -
Identification of biomarker in patients on low dose warfarin : an iTRAQ-coupled LC-MS/MS approach
by: Koh, Regina Hwee Chen.
Published: (2009) -
Comparative proteomics profile of osteoblasts cultured on dissimilar hydroxyapatite biomaterials : an iTRAQ-coupled 2-D LC-MS/MS analysis
by: Khor, Khiam Aik, et al.
Published: (2012) -
LC-MS/MS proteomics analysis of biomarkers in Singapore breast cancer patients on doxorubicin treatment and MCF7 breast cancer derived cells
by: Bahareh Haji Rasouliha
Published: (2011) -
Biomarker identification by LC-MS/MS for patients with brain injury.
by: Low, Keng Cheng.
Published: (2009)